Silencing SOX2‐OT reduced ROS levels and the numbers of NLRP3 inflammasomes and alleviated histopathological lesions and cardiomyocyte fibrosis in rats with VA‐HF. This evidence concerns the gene NLRP3 and hydrops fetalis.